News
Exploring efficacy and safety of oral pirfenidone for progressive, non-IPF lung fibrosis (RELIEF)—a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial. BMC Pulm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback